# Qualitative analysis of genomic mutations and antibiotic susceptibility testing of Pseudomonas aeruginosa isolates from chronic lung infections

**Authors:** Ad C. Fluit, Jumamurat R. Bayjanov, María Díez Aguilar, Rafael Cantón, Deidre F. Gilpin, Michael M. Tunney, Miquel B. Ekkelenkamp

PMC · DOI: 10.1371/journal.pone.0341613 · 2026-03-06

## TL;DR

This study examines how genetic mutations in Pseudomonas aeruginosa relate to antibiotic resistance in patients with chronic lung infections.

## Contribution

The study reveals that multiple genetic changes, rather than single mutations, often contribute to antibiotic resistance in P. aeruginosa.

## Key findings

- Acquired resistance genes were found in 17.1% of isolates but did not explain most resistance cases.
- Multiple amino acid changes in proteins like AmpC and PBP3 were more common in resistant isolates.
- Over half of OXA-β-lactamase variants in isolates were previously undescribed.

## Abstract

P. aeruginosa is intrinsically resistant to many antibiotics and may acquire resistance to others. The aim was to reconcile phenotypic resistance of isolates obtained from patients with chronic respiratory infection with the results of WGS. A total of 497 isolates were recovered from 4 countries between 2002 and 2016 from patients chronic pulmonary conditions, especially cystic fibrosis. Minimum inhibitory concentrations were determined previously by broth microdilution method. Sequencing was performed with Illumina technology and data were analyzed using ResFinder, PubMLST, and the CARD database. In this collection, resistance varied from 4.0% for colistin to 58.8% for ciprofloxacin. Acquired antibiotic resistance genes were found in 17.1% of the isolates, involving six different genes, but could not explain the majority of resistance. Single amino acid changes often did not lead to Minimal Inhibitory Concentrations (MICs) above the EUCAST susceptibility breakpoint. Determining the contribution of each amino acid change to clinical resistance was complicated by the large number of described changes found, the often low frequency of these changes and the high variability of the proteins involved. In particular, the diversity among OXA-ß-lactamases was large; despite over 900 OXA-types in the database, more than half of the variants in the isolate set were undescribed. Resistant isolates frequently had two or more amino acid changes. Four amino acid changes possibly related to β-lactam resistance were more common: two in AmpC (V239A and V356I) and two in PBP3 (R153S and R504C), three of which occurred more often in resistant isolates. Ciprofloxacin resistance could be linked to alterations in GyrA (in particular T82I and D87N) and to loss of or changes in MexZ. AmpD, NfxB, and PmrA, which are associated with resistance, were not detected in similar percentages of resistant and susceptible isolate. It can be concluded that frequently multiple mechanisms make a partial contribution to antibiotic resistance in this set of isolates.

## Linked entities

- **Genes:** ampC (beta-lactamase) [NCBI Gene 878149], pbp3 (penicillin-binding protein) [NCBI Gene 884853], GYRA (DNA GYRASE A) [NCBI Gene 820238], mexZ (efflux pump transcriptional repressor MexZ) [NCBI Gene 77221394], AMPD2 (adenosine monophosphate deaminase 2) [NCBI Gene 271], nfxB (transcriptional regulator NfxB) [NCBI Gene 881079], pmrA (two-component regulator system response regulator PmrA) [NCBI Gene 881834]
- **Diseases:** cystic fibrosis (MONDO:0009061)
- **Species:** Pseudomonas aeruginosa (taxon 287)

## Full-text entities

- **Genes:** oprN (multidrug efflux outer membrane protein OprN) [NCBI Gene 882885], ampR (transcriptional regulator AmpR) [NCBI Gene 877983], GyrA [NCBI Gene 882800], sul1 [NCBI Gene 14678523], OprM [NCBI Gene 877851], nfxB (transcriptional regulator NfxB) [NCBI Gene 881079], mexR (multidrug resistance operon repressor MexR) [NCBI Gene 877857], ParC [NCBI Gene 4290843], mexT (transcriptional regulator MexT) [NCBI Gene 880417], nalC (transcriptional regulator) [NCBI Gene 880362], oprJ (multidrug efflux outer membrane protein OprJ) [NCBI Gene 881070], AmpD [NCBI Gene 881105], NalD [NCBI Gene 880183], pmrA (two-component regulator system response regulator PmrA) [NCBI Gene 881834], ampC (beta-lactamase) [NCBI Gene 878149], fusA1 (elongation factor G) [NCBI Gene 881744], ParE [NCBI Gene 4290845], phoQ (two-component sensor PhoQ) [NCBI Gene 879187], OpmD [NCBI Gene 880347], pmrB (two-component regulator system signal sensor kinase PmrB) [NCBI Gene 881841], OprD [NCBI Gene 881970], AMPD1 (adenosine monophosphate deaminase 1) [NCBI Gene 270] {aka MAD, MADA, MMDD}
- **Diseases:** chronic lung disease (MESH:D029424), CF (MESH:D003550), lung conditions (MESH:D008171), antibiotic (MESH:D004761), lung infection (MESH:D012141), chronic (MESH:D002908), infection (MESH:D007239), bronchiectasis (MESH:D001987), chronic pulmonary infections (MESH:D000088562)
- **Chemicals:** tobramycin (MESH:D014031), tazobactam (MESH:D000078142), gentamicin (MESH:D005839), Carbapenem (MESH:D015780), ceftazidime (MESH:D002442), V (MESH:D014639), Cefepime (MESH:D000077723), Meropenem (MESH:D000077731), Ciprofloxacin (MESH:D002939), 4-amino-4-deoxy-L-arabinose (MESH:C040134), streptomycin (MESH:D013307), monobactams (MESH:D008997), sulfonamide (MESH:D013449), ceftolozane (MESH:C519491), Aminoglycoside (MESH:D000617), piperacillin (MESH:D010878), Ceftolozane/tazobactam (MESH:C000594038), methionine (MESH:D008715), chloramphenicol (MESH:D002701), beta-lactam (MESH:D047090), LPS (MESH:D008070), imipenem (MESH:D015378), fluoroquinolone (MESH:D024841), amikacin (MESH:D000583), cephalosporins (MESH:D002511), Piperacillin/tazobactam (MESH:D000077725), Amino acid (MESH:D000596), ceftazidime-avibactam (MESH:C000595613), aztreonam (MESH:D001398), penicillin (MESH:D010406), fosfomycin (MESH:D005578), OXA-905 (-)
- **Species:** Pseudomonas aeruginosa PAO1 (strain) [taxon 208964], Pseudomonas aeruginosa (species) [taxon 287], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Mycobacterium tuberculosis (species) [taxon 1773]
- **Mutations:** A85, T34I, G148A, A144V, R153S, A28T, T83A, Y85F, A473V, F253L, N242S, D87H, A555E, T188A, H109D, D245G, N373I, E468D, A145V, T43I, N347S, T82I, G195E, T82I, A244T, C245G, S457G, F333L, R153S, G50D, A186T, A248T, F168L, D87N, S87L, Y52N, D87G, R504C, N283S, V239A, C245L, M292I, S87W, V239A, Y555C, G243S, G145E, A38V, D87V, V260G, Y552C, G63S, D45N, F170L, F507L, G242S, R504C, R504, G188S, D87N
- **Cell lines:** PAO1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965580/full.md

---
Source: https://tomesphere.com/paper/PMC12965580